NYSEAMERICAN : MLSS
Milestone Scientific Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 0.3251 USD (Nov 2, 2026, 4:00 AM EST) · Market cap 28.85M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 28.62M |
| Enterprise Value | 27.17M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 88.74M |
| Shares Outstanding | 88.74M |
| Shares Change (YoY) | +5.30% |
| Shares Change (QoQ) | +9.51% |
| Owned by Insiders (%) | 5.98% |
| Owned by Institutions (%) | 5.39% |
| Float | 74.53M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.12 |
| Forward PS | 2.79 |
| PB Ratio | 7.79 |
| P/TBV Ratio | 8.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.85 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -102.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -121.67% |
| Return on Assets (ROA) | -31.28% |
| Return on Invested Capital (ROIC) | -60.25% |
| Return on Capital Employed (ROCE) | -103.88% |
| Weighted Average Cost of Capital (WACC) | 10.35% |
| Revenue Per Employee | $628,078 |
| Profits Per Employee | -$276,247 |
| Employee Count | 15 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 0.80 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -23.12% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.35 |
| Relative Strength Index (RSI) | 41.22 |
| Average Volume (20 Days) | 92,077 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 81,217 |
| Short Previous Month | 91,288 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.11% |
| Short Ratio (days to cover) | 0.86 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 9.42M |
| Gross Profit | 6.62M |
| Operating Income | -4.10M |
| Pretax Income | -4.14M |
| Net Income | -4.14M |
| EBITDA | -4.03M |
| EBIT | -4.10M |
| Loss Per Share | -$0.05 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.07M |
| Total Debt | 615,703 |
| Net Cash | 1.45M |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 3.47M |
| Book Value Per Share | 0.04 |
| Working Capital | 3.72M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -642,639 |
| Capital Expenditures | -15,119 |
| Depreciation & Amortization | 78,301 |
| Net Borrowing | -14,815 |
| Free Cash Flow | -657,758 |
| FCF Per Share | -$0.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | 70.23% |
| Operating Margin | -43.56% |
| Pretax Margin | -43.98% |
| Profit Margin | -43.98% |
| EBITDA Margin | -42.73% |
| EBIT Margin | -43.56% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.30% |
| Shareholder Yield | -5.30% |
| Earnings Yield | -15.15% |
| FCF Yield | -2.24% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $1.25 |
| Price Target Difference | 287.60% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 16.09% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 14, 2004 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -18.77 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |